149
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

Cilostazol in patients with ischemic stroke

, MD, , DO & , MD
Pages 1305-1315 | Published online: 06 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kensuke Noma & Yukihito Higashi. (2018) Cilostazol for treatment of cerebral infarction. Expert Opinion on Pharmacotherapy 19:15, pages 1719-1726.
Read now

Articles from other publishers (5)

Ha Na Kim, Tae-Youn Kim, Young Hee Yoon & Jae-Young Koh. (2015) Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death. Brain Research 1628, pages 317-326.
Crossref
Ashish K. Rehni, Neha Nautiyal, Miguel A. Perez-Pinzon & Kunjan R. Dave. (2014) Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics. Metabolic Brain Disease 30:2, pages 437-447.
Crossref
Nejal M. Bhatt, Vijay D. Chavada, Daxesh P. Patel, Primal Sharma, Mallika Sanyal & Pranav S. Shrivastav. (2015) Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS. Journal of Pharmaceutical Analysis 5:1, pages 1-11.
Crossref
Esteban Cheng-ChingEdgar A. SamaniegoBharath Reddy NaravetlaOsama O. ZaidatMuhammad Shazam Hussain. (2012) Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics. Neurology 79:13_supplement_1.
Crossref
KIYOSHI KIKUCHI, KO-ICHI KAWAHARA, NAOKI MIURA, TAKASHI ITO, YOKO MORIMOTO, SALUNYA TANCHAROEN, NOBUYUKI TAKESHIGE, HISAAKI UCHIKADO, ROKUDAI SAKAMOTO, NAOHISA MIYAGI, CHIEMI KIKUCHI, NARUMI IIDA, NAOTO SHIOMI, TERUKAZU KURAMOTO, MASARU HIROHATA, IKURO MARUYAMA, MOTOHIRO MORIOKA & EIICHIRO TANAKA. (2012) Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy. Experimental and Therapeutic Medicine 4:1, pages 3-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.